CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12,000 enrolled
Drug / intervention
transcatheter aortic valve implantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03588247
NCT03588247N/ACompleted
CompareCT.gov

Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)·observational·Posted Jul 17, 2018·Updated Apr 26, 2024

In Brief

An observational study evaluating transcatheter aortic valve implantation for Aortic Valve Stenosis. Completed, enrolled 12,000 participants across 1 site.

Detailed Summary

The aim of this collaborative analysis is to evaluate stroke rates and mortality in patients undergoing TAVI with the self-expandable MCV prosthesis compared to the balloon-expandable ES valve. In the absence of large randomized controlled trials, we will conduct a large collaborative patient-pooled meta-analysis on 30-day stroke and mortality in patients undergoing primary transfemoral TAVI with either MCV or ES valve.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 17, 2018
Enrollment StartAug 1, 2017
Primary CompletionJun 1, 2018
Study CompletionJan 1, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.0 years ago

Interventions

transcatheter aortic valve implantationprocedure

Patients with severe aortic valve stenosis undergo transcatheter aortic valve implantation